Skip navigation
Skip navigation

Targeting MYC-driven growth and proliferation in prostate cancer

Rebello, R.; Drygin, D.; Cameron, D.; Risbridger, G.P.; Pearson, R.B.; Hannan, R.D.; Furic, L.


Over the last decade, the oncogene MYC has emerged as a key driver of survival, growth and proliferation in prostate cancer. The transforming activity of this potent oncogene partly depends on its ability to modulate RNA Pol I transcription activity which is required for ribosome synthesis. Considering that cancer cells are dependent on high rates of RNA Pol I transcription, we explored the efficacy of targeting PolI transcription with a small molecule inhibitor in prostate cancer.

CollectionsANU Research Publications
Date published: 2014-07
Type: Conference poster
Source: European Journal of Cancer
DOI: 10.1016/S0959-8049(14)50676-4


File Description SizeFormat Image
1-s2.0-S0959804914506764-main.pdfConference abstract65.53 kBAdobe PDFThumbnail
    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  19 May 2020/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator